Southland Equity Partners LLC Amgen Inc Transaction History

Southland Equity Partners LLC

$411 Billion
Q3 2024

A detailed history of Southland Equity Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Southland Equity Partners LLC holds 1,569 shares of AMGN stock, worth $454,853. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,569

Previous 1,570 0.06%

Holding current value

$454,853

Previous $491 Million 3.07%

% of portfolio

0.12%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $309 - $337	-1 Reduced 0.06%	1,569 $506 Million
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $2,890 - $3,512	11 Added 0.71%	1,570 $491 Million
Q1 2024 Apr 12, 2024	BUY	$268.87 - $324.56 $5,646 - $6,815	21 Added 1.37%	1,559 $443 Million
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $8,693 - $9,807	34 Added 2.26%	1,538 $443 Million
Q3 2023 Jan 02, 2024	BUY	$218.65 - $271.46 $41,106 - $51,034	188 Added 14.29%	1,504 $404 Million
Q2 2023 Jan 02, 2024	BUY	$214.27 - $253.37 $2,571 - $3,040	12 Added 0.92%	1,316 $292 Million
Q1 2023 Jan 02, 2024	SELL	$225.79 - $275.2 $26,191 - $31,923	-116 Reduced 8.17%	1,304 $315 Million
Q4 2022 Jan 02, 2024	BUY	$229.03 - $291.01 $97,566 - $123,970	426 Added 42.86%	1,420 $373 Million
Q3 2022 Jan 02, 2024	SELL	$224.46 - $253.15 $4,938 - $5,569	-22 Reduced 2.17%	994 $224 Million
Q2 2022 Jan 02, 2024	BUY	$230.71 - $256.74 $10,151 - $11,296	44 Added 4.53%	1,016 $247 Million
Q1 2022 Jan 02, 2024	BUY	$219.27 - $242.57 $213,130 - $235,778	972 New	972 $235 Million
Q3 2021 Jan 02, 2024	SELL	$212.27 - $248.7 $183,825 - $215,374	-866 Closed	0 $0
Q2 2021 Jan 02, 2024	BUY	$233.58 - $259.14 $1,167 - $1,295	5 Added 0.58%	866 $211 Million
Q1 2021 Jan 02, 2024	BUY	$221.91 - $258.6 $191,064 - $222,654	861 New	861 $214 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Southland Equity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Southland Equity Partners LLC with notifications on news.

Account

Southland Equity Partners LLC Amgen Inc Transaction History